Table 3.
Antenatal factors associated with SGA status at NICU discharge, BBC.
| Discharge SGA (n = 231) | Discharge AGA (n = 805) | P value | |
|---|---|---|---|
| Birth weight (g)a | 1451.87 (527.63) | 1795.04 (633.13) | <0.01 |
| Birth head circumference (cm)a | 28.09 (3.44) | 29.12 (3.17) | <0.01 |
| Birth length (cm)a | 40.15 (4.85) | 42.03 (4.77) | <0.01 |
| Gestational age (GA) in weeksa | 32.03 (3.58) | 31.90 (3.17) | 0.58 |
| Genderb | 0.28 | ||
| Male | 112 (48.48%) | 420 (52.50%) | |
| Female | 119 (51.52%) | 380 (47.50%) | |
| 1 min APGARa | 5.64 (2.58) | 6.14 (2.36) | 0.03 |
| 5 min APGARa | 7.3 (1.98) | 7.7 (1.46) | 0.01 |
| Maternal raceb | 0.45 | ||
| Black | 129 (61.14%) | 334 (59.57%) | |
| Non-Black | 82 (38.86%) | 222 (39.71%) | |
| Maternal ageb | 0.66 | ||
| 20–35 (ref) | 143 (67.77%) | 381 (68.48%) | |
| <20 | 20 (9.48%) | 53 (9.67%) | |
| >35 | 48 (22.75%) | 121 (21.85%) | |
| Maternal educationb | <0.01 | ||
| Above high school (HS) | 74 (32.03%) | 185 (22.98%) | |
| Below HS | 64 (27.71%) | 170 (21.12%) | |
| HS | 73 (31.60%) | 200 (24.84%) | |
| Unknown | 20 (8.66%) | 250 (31.06%) | |
| Maternal parityb | <0.01 | ||
| Nulliparous | 104 (45.02%) | 228 (28.32%) | |
| Multiparous | 107 (46.32%) | 327 (40.62%) | |
| Unknown | 20 (8.66%) | 250 (31.06%) | |
| Intrauterine drug exposureb | 30 (12.99%) | 39 (4.84%) | <0.01 |
| Ever smokedb | 66 (28.57%) | 149 (18.51%) | 0.001 |
| Placenta informationb | <0.01 | ||
| No inflammation and no MVM (ref.) | 73 (31.6%) | 347 (43.11%) | |
| Inflammation only | 27 (11.69%) | 193 (23.98%) | |
| MVM only | 112 (48.48%) | 210 (26.09%) | |
| Both Inflammation and MVM | 19 (8.23%) | 55 (6.83%) | |
| Antenatal steroid (any)b | 135 (21.46%) | 494 (78.54%) | 0.64 |
| Doses of antenatal steroidb | <0.01 | ||
| 0 dose | 115 (49.78%) | 531 (65.96%) | |
| 1 dose | 25 (10.82%) | 66 (8.20%) | |
| ≥2 dose | 91 (39.39%) | 208 (25.84%) |
Data presented as counts (percentage) or mean (SD).
at-test analysis.
bchi square analysis.